azathioprine has been researched along with Respiratory Tract Diseases in 10 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-five patients with Wegener's granulomatosis were studied for 21 years at the National Institutes of Health." | 3.75 | Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. ( Fauci, AS; Haynes, BF; Katz, P; Wolff, SM, 1983) |
| "Since relapses are frequent, these patients should be evaluated frequently." | 1.31 | Wegener granulomatosis in children and young adults. A case study of ten patients. ( Gothefors, L; Malmer, B; Müller Wiefel, DE; Nilsson, K; Stegmayr, BG; Sundelin, B, 2000) |
| "In the azathioprine group, respiratory infections accounted for 24 of 60 (40%) infections." | 1.27 | Respiratory complications of cardiac transplantation. ( Drusin, R; Enson, Y; Reemtsma, K; Rose, EA; Schulman, LL; Smith, CR, 1988) |
| "20 patients with myasthenia gravis (MG), refractory to anticholinesterase and steroid therapy, underwent plasma exchange therapy combined with immunosuppressive drugs and lymphocytapheresis." | 1.26 | Plasma exchange combined with cytotoxic drugs and lymphocytapheresis for myasthenia gravis. ( Cornelio, F; Forlani, G; Garelli, S; Pelucchetti, D; Valbonesi, M; Zerbi, D, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, J | 1 |
| Yamano, Y | 1 |
| Kawahata, K | 1 |
| Suzuki, N | 1 |
| Lynch, JP | 1 |
| Tazelaar, H | 1 |
| Fauci, AS | 2 |
| Haynes, BF | 1 |
| Katz, P | 1 |
| Wolff, SM | 2 |
| Valbonesi, M | 1 |
| Garelli, S | 1 |
| Zerbi, D | 1 |
| Forlani, G | 1 |
| Cornelio, F | 1 |
| Pelucchetti, D | 1 |
| Shumway, SJ | 1 |
| Hertz, MI | 1 |
| Maynard, R | 1 |
| Kshettry, VR | 1 |
| Bolman, RM | 1 |
| Stegmayr, BG | 1 |
| Gothefors, L | 1 |
| Malmer, B | 1 |
| Müller Wiefel, DE | 1 |
| Nilsson, K | 1 |
| Sundelin, B | 1 |
| Schulman, LL | 1 |
| Smith, CR | 1 |
| Drusin, R | 1 |
| Rose, EA | 1 |
| Enson, Y | 1 |
| Reemtsma, K | 1 |
| Horn, RG | 1 |
| Dale, DC | 1 |
| Harrison, DF | 1 |
| Hagedorn, M | 1 |
| Maas, D | 1 |
| Bilger, R | 1 |
| Mittermayer, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I/II Trial of TNFR:Fc (Etanercept) in Patients With Wegener's Granulomatosis[NCT00001901] | Phase 2 | 60 participants | Interventional | 1999-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for azathioprine and Respiratory Tract Diseases
| Article | Year |
|---|---|
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.
Topics: Adolescent; Adult; Aged; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Administrati | 1983 |
1 trial available for azathioprine and Respiratory Tract Diseases
| Article | Year |
|---|---|
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.
Topics: Adolescent; Adult; Aged; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Administrati | 1983 |
9 other studies available for azathioprine and Respiratory Tract Diseases
| Article | Year |
|---|---|
Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019 demonstrates reduction of airway involvement compared with that in 2009.
Topics: Adult; Azathioprine; Cross-Sectional Studies; Cyclophosphamide; Female; Humans; Immunosuppressive Ag | 2022 |
Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cy | 2011 |
Plasma exchange combined with cytotoxic drugs and lymphocytapheresis for myasthenia gravis.
Topics: Azathioprine; Cell Separation; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Leukapher | 1982 |
Airway complications after lung and heart-lung transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Heart-Lung Transplantation; Humans; Immunosuppress | 1993 |
Wegener granulomatosis in children and young adults. A case study of ten patients.
Topics: Adolescent; Adult; Antigen-Antibody Reactions; Azathioprine; Child; Cyclophosphamide; Disease Progre | 2000 |
Respiratory complications of cardiac transplantation.
Topics: Adult; Azathioprine; Cyclosporins; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; P | 1988 |
Wegener's granulomatosis.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Diagnosis, Differe | 1974 |
Non-healing granulomata of the upper respiratory tract.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Blood Sedimentation; Child; Female; | 1974 |
[Papulosis atrophicans maligna (Köhlmeier-Degos) and Wegener's granulomatosis in a sister and brother (author's transl)].
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cyclophosphamide; Diet Therapy; Female; Glutens; Granul | 1974 |